Metropolis Healthcare Q2 revenue rises 16 pc to Rs 497 crore, PAT up 43 pc

Mumbai, Nov 3 (TNT): Metropolis Healthcare Limited on Tuesday reported a 15.8 per cent year-on-year growth in consolidated revenue from operations at Rs 496.8 crore for the second quarter ended September 30, 2026, while net profit increased 42.7 per cent to Rs 75.5 crore.

The diagnostic services provider’s reported EBITDA rose 23.9 per cent to Rs 134.9 crore during the quarter, with the EBITDA margin improving by 180 basis points to 27.2 per cent.

Patient volumes increased 10 per cent year-on-year to 4.1 million, while test volumes grew 11 per cent to 8.7 million, reflecting sustained demand for diagnostic services, the company said in a statement.

Business-to-consumer (B2C) revenue grew 17 per cent to Rs 289 crore, while business-to-business (B2B) revenue increased 15 per cent to Rs 208 crore. TruHealth revenue rose 20 per cent to Rs 86 crore, while specialty revenue also grew 20 per cent to Rs 198 crore.

Revenue per patient increased 6 per cent to Rs 1,221, while revenue per test improved 5 per cent to Rs 572.

Tier-III cities remained the fastest-growing markets, recording around 20 per cent revenue growth.

The company now reaches around 750 towns through 5,119 service points.

For the first half of FY27, revenue from operations increased 16.2 per cent to Rs 947 crore, while reported EBITDA rose 25.3 per cent to Rs 248.2 crore. Net profit grew 34.9 per cent to Rs 132.4 crore.

The board has declared an interim dividend of Rs 1 per share.

Metropolis Healthcare Promoter and Executive Chairperson Ameera Shah said the company would focus on strengthening its genomics and scientific capabilities, leveraging technology to improve patient experience and pursuing strategic acquisitions.

She said the company’s Metropolis 3.0 strategy aimed at building capabilities for the next phase of the Indian diagnostics sector.

TNT KM